Filing Details
- Accession Number:
- 0000711377-20-000016
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2020-02-27 08:57:53
- Reporting Period:
- 2020-02-18
- Accepted Time:
- 2020-02-27 08:57:53
- Original Submission Date:
- 2020-02-19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
711377 | Neogen Corp | NEOG | In Vitro & In Vivo Diagnostic Substances (2835) | 382367843 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1168789 | L James Herbert | Neogen Corp 620 Lesher Place Lansing MI 48912 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-02-18 | 14,614 | $72.04 | 89,456 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- These shares wee sold according to the terms of a Rule 10(b)5-1 plan filed by the reporting person on December 27, 2019